Smith Philip W, Wang Hongkun, Gazoni Leo M, Shen K Robert, Daniel Thomas M, Jones David R
Department of Surgery, University of Virginia, Charlottesville, Virginia 22908-0679, USA.
Ann Thorac Surg. 2007 Oct;84(4):1098-105; discussion 1105-6. doi: 10.1016/j.athoracsur.2007.04.033.
The effect of obesity on complications after resection for lung cancer is unknown. We hypothesized that obesity is associated with increased complications after anatomic resections for non-small cell lung cancer.
A review of our prospective general thoracic database identified 499 consecutive anatomic resections for non-small cell lung cancer from November 2002 to May 2006. Body mass index (BMI) was used to group patients as nonobese (BMI > 18.5 to < 30) and obese (BMI > or = 30). Patient characteristics and oncologic and operative variables were compared between groups. Multivariable logistic regression models were fit with BMI included at every level. Outcomes examined included in-hospital morbidity, mortality, length of stay, and readmission.
Seventy-five percent (372 of 499) were nonobese, and 25% (127 of 499) were obese. Preoperative variables were similar, except for a greater incidence of diabetes mellitus (p < 0.0001) in the obese group. Overall mortality was 1.4% (7 of 499) and was not different between groups (p = 0.85). Thirty-day readmission rates (p = 0.76) and length of stay (p = 0.30) were similar. Obese patients had a higher incidence of acute renal failure (p = 0.001). A complication occurred in 33% (124 of 372) of nonobese and 31% (39 of 127) of obese patients (p = 0.59). Respiratory complications occurred in 22% (81 of 372) of nonobese and 14% (18 of 127) of obese patients (p = 0.06). Significant predictors of any complication include performance status, diffusing capacity, and tumor stage. Significant predictors of respiratory complications include performance status, diffusing capacity, chronic renal insufficiency, prior thoracic surgery, and chest wall resection.
In contrast to our hypothesis, obesity does not increase the incidence of perioperative complications, mortality, or length of stay after anatomic resection for non-small cell lung cancer.
肥胖对肺癌切除术后并发症的影响尚不清楚。我们推测肥胖与非小细胞肺癌解剖切除术后并发症增加有关。
回顾我们前瞻性的普通胸外科数据库,确定了2002年11月至2006年5月期间连续499例非小细胞肺癌解剖切除术。使用体重指数(BMI)将患者分为非肥胖组(BMI>18.5至<30)和肥胖组(BMI≥30)。比较两组患者的特征、肿瘤学和手术变量。多变量逻辑回归模型在每个水平上都纳入了BMI。检查的结果包括住院发病率、死亡率、住院时间和再入院率。
75%(499例中的372例)为非肥胖患者,25%(499例中的12块)为肥胖患者。术前变量相似,但肥胖组糖尿病发病率更高(p<0.0001)。总体死亡率为1.4%(499例中的7例),两组之间无差异(p = 0.85)。30天再入院率(p = 0.76)和住院时间(p = 0.30)相似。肥胖患者急性肾衰竭的发生率更高(p = 0.001)。非肥胖患者中有33%(372例中的124例)发生并发症,肥胖患者中有31%(127例中的39例)发生并发症(p = 0.59)。非肥胖患者中有22%(372例中的81例)发生呼吸并发症,肥胖患者中有14%(127例中的18例)发生呼吸并发症(p = 0.06)。任何并发症的显著预测因素包括体能状态、弥散能力和肿瘤分期。呼吸并发症的显著预测因素包括体能状态、弥散能力、慢性肾功能不全、既往胸外科手术和胸壁切除术。
与我们的假设相反,肥胖并不会增加非小细胞肺癌解剖切除术后围手术期并发症的发生率、死亡率或住院时间。